These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8215265)

  • 1. Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trial.
    Islam A; Butler T; Kabir I; Alam NH
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1572-5. PubMed ID: 8215265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of typhoid fever: randomized trial of a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol.
    Acharya G; Butler T; Ho M; Sharma PR; Tiwari M; Adhikari RK; Khagda JB; Pokhrel B; Pathak UN
    Am J Trop Med Hyg; 1995 Feb; 52(2):162-5. PubMed ID: 7872445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized treatment of patients with typhoid fever by using ceftriaxone or chloramphenicol.
    Islam A; Butler T; Nath SK; Alam NH; Stoeckel K; Houser HB; Smith AL
    J Infect Dis; 1988 Oct; 158(4):742-7. PubMed ID: 3171225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of typhoid fever in children with a flexible-duration of ceftriaxone, compared with 14-day treatment with chloramphenicol.
    Tatli MM; Aktas G; Kosecik M; Yilmaz A
    Int J Antimicrob Agents; 2003 Apr; 21(4):350-3. PubMed ID: 12672582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of typhoid fever for three days with ceftriaxone].
    Lasserre R
    Bull Soc Pathol Exot; 1990; 83(4):468-72. PubMed ID: 2286000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-day treatment of typhoid fever with two different doses of ceftriaxone, compared to 14-day therapy with chloramphenicol: a randomized trial.
    Lasserre R; Sangalang RP; Santiago L
    J Antimicrob Chemother; 1991 Nov; 28(5):765-72. PubMed ID: 1778879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once daily ceftriaxone vs. chloramphenicol for treatment of typhoid fever in children.
    Moosa A; Rubidge CJ
    Pediatr Infect Dis J; 1989 Oct; 8(10):696-9. PubMed ID: 2812914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone versus chloramphenicol in the treatment of enteric fever.
    Girgis NI; Kilpatrick ME; Farid Z; Mikhail IA; Bishay E
    Drugs Exp Clin Res; 1990; 16(12):607-9. PubMed ID: 2130002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children.
    Frenck RW; Nakhla I; Sultan Y; Bassily SB; Girgis YF; David J; Butler TC; Girgis NI; Morsy M
    Clin Infect Dis; 2000 Nov; 31(5):1134-8. PubMed ID: 11073741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children.
    Dutta P; Mitra U; Dutta S; De A; Chatterjee MK; Bhattacharya SK
    Indian J Med Res; 2001 Jun; 113():210-3. PubMed ID: 11816954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India.
    Butler T; Sridhar CB; Daga MK; Pathak K; Pandit RB; Khakhria R; Potkar CN; Zelasky MT; Johnson RB
    J Antimicrob Chemother; 1999 Aug; 44(2):243-50. PubMed ID: 10473232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic aspects of typhoidal salmonellosis in childhood: the Karachi experience.
    Bhutta ZA
    Ann Trop Paediatr; 1996 Dec; 16(4):299-306. PubMed ID: 8985527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparative study of fleroxacin and chloramphenicol in typhoid fever.
    Arnold K; Hong CS; Nelwan R; Zavala-Trujillo I; Kadio A; Barros MA; de Garis S
    Am J Med; 1993 Mar; 94(3A):195S-200S. PubMed ID: 8452180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of aztreonam and chloramphenicol in treatment of typhoid fever.
    Gotuzzo E; Echevarría J; Carrillo C; Sánchez J; Grados P; Maguiña C; DuPont HL
    Antimicrob Agents Chemother; 1994 Mar; 38(3):558-62. PubMed ID: 8203854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trial.
    Arjyal A; Basnyat B; Nhan HT; Koirala S; Giri A; Joshi N; Shakya M; Pathak KR; Mahat SP; Prajapati SP; Adhikari N; Thapa R; Merson L; Gajurel D; Lamsal K; Lamsal D; Yadav BK; Shah G; Shrestha P; Dongol S; Karkey A; Thompson CN; Thieu NTV; Thanh DP; Baker S; Thwaites GE; Wolbers M; Dolecek C
    Lancet Infect Dis; 2016 May; 16(5):535-545. PubMed ID: 26809813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftriaxone therapy in bacteremic typhoid fever.
    Ti TY; Monteiro EH; Lam S; Lee HS
    Antimicrob Agents Chemother; 1985 Oct; 28(4):540-3. PubMed ID: 4073877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized clinical trial of furazolidone for typhoid fever in children.
    Dutta P; Rasaily R; Saha MR; Mitra U; Manna B; Chakraborty S; Mukherjee A
    Scand J Gastroenterol; 1993 Feb; 28(2):168-72. PubMed ID: 8441910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever.
    Smith MD; Duong NM; Hoa NT; Wain J; Ha HD; Diep TS; Day NP; Hien TT; White NJ
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1716-20. PubMed ID: 7986000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of Salmonellae in blood and bone marrow: randomized controlled trial comparing ciprofloxacin and chloramphenicol treatments against enteric fever.
    Gasem MH; Keuter M; Dolmans WM; Van Der Ven-Jongekrijg J; Djokomoeljanto R; Van Der Meer JW
    Antimicrob Agents Chemother; 2003 May; 47(5):1727-31. PubMed ID: 12709347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome in three groups of patients with typhoid fever in Indonesia between 1948 and 1990.
    van den Bergh ET; Gasem MH; Keuter M; Dolmans MV
    Trop Med Int Health; 1999 Mar; 4(3):211-5. PubMed ID: 10223217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.